Lichen Capital
Overview
Lichen Capital is a Chinese private equity firm specializing in healthcare and biotechnology investments. The firm focuses on buyout and significant minority opportunities, with a track record spanning over 15 years and assets under management totaling $3.9 billion. Their investment approach is industry-oriented, targeting sectors such as pharmaceuticals, biotechnology, medical devices, healthcare services, and in vitro diagnostics. Lichen Capital has completed 9 buyouts, including 5 exits, achieving a gross multiple on invested capital of 5.1x across realized buyouts. The firm has a low realized loss rate of approximately 1% across its private equity investments in all USD funds. Lichen Capital's portfolio includes companies in pharmaceuticals, medical devices, healthcare services, and in vitro diagnostics, among others. Their investment strategy emphasizes value creation through operational improvements and strategic growth initiatives. The firm has a strong presence in both domestic and international capital markets, with experience in eight major markets, including China, Hong Kong, the United States, Germany, Singapore, South Korea, Taiwan, and the Netherlands. Lichen Capital's senior operation team, robust financial strength, and extensive intermediary resources enable enterprises to achieve listing at lower cost, lower risk, and faster speed. The firm's commitment to the healthcare and biotechnology sectors is underscored by its substantial investments and active involvement in these industries. Lichen Capital's approach combines deep industry knowledge with a focus on value creation, aiming to drive growth and innovation within its portfolio companies. Their strategic investments are designed to enhance operational efficiencies and foster long-term success in the healthcare and biotechnology sectors.
Investment Focus
- Established companies with strong growth potential in healthcare and biotechnology sectors
- Opportunities for operational improvements and strategic growth
- Companies seeking buyout or significant minority investments
Portfolio Companies
Reach Lichen Capital directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Lichen Capital
What sectors does Lichen Capital invest in?
Lichen Capital invests in Healthcare, Healthcare Services, Pharmaceuticals, Medical Devices, Biotechnology and Medical Equipment, and is based in Fujian, China. Lichen Capital is listed as a private equity in the ConnectSafely investor database.
What stage does Lichen Capital invest at?
Lichen Capital backs companies at Growth, Late Stage, Pre-IPO and Buyout, writing cheques of 5M - 50M.
Which regions does Lichen Capital invest in?
Lichen Capital invests across United States, Germany, Singapore, China, South Korea and Netherlands.
What companies has Lichen Capital invested in?
Lichen Capital's portfolio includes WeWork, PizzaExpress, Zoomlion, Shanghai City Investment Holdings, Shanghai Jin Jiang International, ENN, STX and SciClone.
Last updated · Source: ConnectSafely investor database
